Table 1.
Variables | TN | Controls | p-Value |
---|---|---|---|
Patients, n | 16 | 16 | |
Age (years), median (IQR) | 66 (55–69) | 67 (52–72) | 1.00 |
Sex (female/male), n (%) | 7/9 (44/56%) | 6/10 (38/63%) | 0.72 |
BMI, median (IQR) | 28 (24–31) | 28 (24–31) | 0.93 |
Tobacco use, n (%) | 4 (25%) | 8 (50%) | 0.14 |
Hypertension, n (%) | 8 (50%) | 9 (56%) | 0.72 |
Cardiovascular morbidity, n (%) | 2 (13%) | 5 (31%) | 0.22 |
Ischemic heart disease, n (%) | 1 (6%) | 3 (19%) | |
Stroke, n (%) | 1 (6%) | 1 (6%) | |
Peripheral, n (%) | 0 (0%) | 1 (6%) | |
Diabetes mellitus, n (%) | 0 (0%) | 3 (19%) | 0.07 |
Pain other than TN, n (%) | 4 (25%) | 5 (31%) | 0.69 |
Fibromyalgia, n (%) | 1 (6%) | 0 (0%) | |
Osteoarthtritis, n (%) | 2 (13%) | 2 (13%) | |
Lower back pain, n (%) | 1 (6%) | 2 (13%) | |
Rheumatoid arthritis, n (%) | 1 (6%) | 1 (6%) | |
ASA grade | 0.83 | ||
1, n (%) | 2 (13%) | 2 (13%) | |
2, n (%) | 13 (81%) | 12 (75%) | |
3, n (%) | 1 (6%) | 2 (13%) |
Lumbar CSF—in TN patients and controls.